Home/Filings/4/0001104659-23-122840
4//SEC Filing

Mehra Raj 4

Accession 0001104659-23-122840

CIK 0001017491other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 4:16 PM ET

Size

7.6 KB

Accession

0001104659-23-122840

Insider Transaction Report

Form 4
Period: 2023-12-01
Mehra Raj
DirectorSee Remarks10% Owner
Transactions
  • Purchase

    Common Stock

    2023-12-01$1.32/sh+75,757$99,999185,142 total
  • Purchase

    Common Stock Warrant (right to buy)

    2023-12-01+75,75775,757 total
    Exercise: $1.32From: 2023-12-01Exp: 2028-12-01Common Stock (75,757 underlying)
Footnotes (2)
  • [F1]Each share of common stock was purchased together with an accompanying warrant to purchase one share of common stock in an underwritten public offering at a combined offering price of $1.32 per share of common stock and accompanying warrant.
  • [F2]Effective on November 28, 2023, the Issuer conducted a reverse stock split at a ratio of 1-for-30 (the "Reverse Split"). The number of shares reported herein reflects the number of shares after the Reverse Split.

Issuer

SEELOS THERAPEUTICS, INC.

CIK 0001017491

Entity typeother

Related Parties

1
  • filerCIK 0001757892

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:16 PM ET
Size
7.6 KB